Author:
Caimmi Davide,Clark Evangéline,Fogel Paul,Heddebaut Nicolas,Aubier Michel,Demoly Pascal
Abstract
<b><i>Background:</i></b> Patients suffering from allergic rhinitis seek for several therapeutic symptomatic options, including nonconventional treatments, to control their symptoms. <b><i>Objectives:</i></b> Through the present proof-of-concept study, we prospectively investigated the potential role of Puressentiel<sup>®</sup> nasal protection spray (SNPA) in patients suffering from cypress pollen allergic rhinitis. <b><i>Methods:</i></b> In 15 adults, we performed two nasal provocation tests, with a cypress pollen extract, with a 15-day interval, with and without previous randomized administration of SNPA, and evaluated a nasal symptom score, the nasal inspiratory peak flow, and the concentration of inflammatory cytokines in the nasal lavage after the procedures. <b><i>Results:</i></b> Comparing results in patients challenged with and without the SNPA spray before the nasal challenge, we found a 57% mean decrease in symptoms, and a 62% average difference in inspiratory peak flow, after the use of the spray. <b><i>Conclusions:</i></b> Puressentiel<sup>®</sup> SNPA is effective in reducing nasal symptoms, as assessed by nasal symptoms score and nasal inspiratory peak flow, and could be a valid natural non-pharmacological option in patients suffering from allergic rhinitis.
Subject
Immunology,General Medicine,Immunology and Allergy